One study reported that thymoquinone reduced NF-κB activity and increased caspase-3 levels in a HepG2 cancer cell line [57], supporting the idea that thymoquinone’s anti-inflammatory effects align with its pro-apoptotic effects. This evidence concerns the gene NFKB1 and cancer.